Date published: 2026-5-2

1-800-457-3801

SCBT Portrait Logo
Seach Input

nm23-H1 Activators

nm23-H1 activators represent a group of structurally diverse chemicals capable of upregulating expression of the nm23-H1 metastasis suppressor gene. While differing in their composition, nm23-H1 activators converge on their ability to stimulate nm23-H1 transcription. Many nm23-H1 activators mediate their effects through nuclear receptor engagement or activation of cellular signaling networks. Binding receptors triggers formation of transcription factor complexes directed to specific promoter elements in the nm23-H1 gene. This augments recruitment of RNA polymerase and other proteins required for transcriptional initiation. Alternatively, some activators mobilize signal transduction pathways that modulate activities of DNA-binding transcriptional regulators.

Additionally, certain nm23-H1 activators may exert influences through altering broader cellular processes involved in gene regulation, such as epigenetics, stress responses or homeostasis. Disruption of such general pathways could indirectly impact the transcriptional milieu governing nm23-H1 expression. Irrespective of the exact molecular mechanisms employed, all nm23-H1 activators collectively function to increase nm23-H1 mRNA and protein production across diverse cell contexts. Elucidating the varied strategies used by this class of compounds to stimulate nm23-H1 transcription has contributed significantly to current understanding of genetic control over nm23-H1 and its role in cancer progression. Continued investigation may provide novel insights into pathways that modify nm23-H1 expression in health and disease.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Lysophosphatidic Acid

325465-93-8sc-201053
sc-201053A
5 mg
25 mg
$98.00
$341.00
50
(3)

LPA (Lysophosphatidic Acid) triggers PKC and Rho GTPase signaling cascades that modify activities of ELK1, SRF and other factors binding SRE/Ets motifs to activate nm23-H1 transcription.

Retinoic Acid, all trans

302-79-4sc-200898
sc-200898A
sc-200898B
sc-200898C
500 mg
5 g
10 g
100 g
$66.00
$325.00
$587.00
$1018.00
28
(1)

All-trans retinoic acid stimulates RAR:RXR dimer formation binding to RARE sites, initiating enhanced nm23-H1 mRNA synthesis.

Sulindac

38194-50-2sc-202823
sc-202823A
sc-202823B
1 g
5 g
10 g
$32.00
$86.00
$150.00
3
(1)

Sulindac metabolites activate PPARγ receptors dimerizing with RXR at PPRE sequences to stimulate nm23-H1 gene transcription.

Etoposide (VP-16)

33419-42-0sc-3512B
sc-3512
sc-3512A
10 mg
100 mg
500 mg
$51.00
$231.00
$523.00
63
(1)

Etoposide causes topoisomerase II poisoning inducing DDR pathways. This activates CHK2 phosphorylating HMGA1 enabling binding to minisatellite repeats and nm23-H1 upregulation.

Valproic Acid

99-66-1sc-213144
10 g
$87.00
9
(1)

VPA is an HDAC inhibitor inducing chromatin remodeling changes permitting transcription factor binding at the nm23-H1 promoter site.

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$60.00
$265.00
$1000.00
163
(3)

MG-132 inhibits the proteasome increasing ROS production. This activates Nrf2 translocating to the nucleus where it binds ARE motifs to regulate nm23-H1 transcription.